dc.contributor.author |
Gouws, JF
|
|
dc.contributor.author |
Majozi, T
|
|
dc.date.accessioned |
2008-01-17T08:04:38Z |
|
dc.date.available |
2008-01-17T08:04:38Z |
|
dc.date.issued |
2007-05 |
|
dc.identifier.citation |
Gouws, JF, and Majozi, T. 2007. Towards the design of a zero effluent facility in the pharmaceutical industry. 10th Conference on Process Integration, Modelling and Optimisation for Energy Saving and Pollution Reduction, Ischia Island, Gulf of Naples, 24-27 June 2007, pp. 1-6 |
en |
dc.identifier.uri |
http://hdl.handle.net/10204/1849
|
|
dc.description.abstract |
One of the main goals of any production facility is to have the least negative effect on the surrounding environment, while still producing the required output. The perfect scenario would be a production facility that produces zero effluents. The pharmaceutical production industry has some unique characteristics that make it possible to reach the goal of zero effluent. In such industries wastewater is generally produced from washing out of mixing vessels. The wastewater thus contains valuable product residue. It is possible, under the correct conditions, to reuse the wastewater as part of the formulation of a subsequent batch of a compatible product, thereby producing zero effluent from the operation. From this the question arises on the design of the production facility as to maximise the opportunity to reuse the wastewater, thus producing zero effluent, and keeping the capital costs of such a plant to a minimum. The derived methodology addresses the design aspect of a zero effluent pharmaceutical facility. The methodology takes storage and scheduling of the pharmaceutical operation into consideration. |
en |
dc.language.iso |
en |
en |
dc.subject |
Zero effluent |
en |
dc.subject |
Batch processing |
en |
dc.subject |
pharmaceutical production |
en |
dc.title |
Towards the design of a zero effluent facility in the pharmaceutical industry |
en |
dc.type |
Conference Presentation |
en |
dc.identifier.apacitation |
Gouws, J., & Majozi, T. (2007). Towards the design of a zero effluent facility in the pharmaceutical industry. http://hdl.handle.net/10204/1849 |
en_ZA |
dc.identifier.chicagocitation |
Gouws, JF, and T Majozi. "Towards the design of a zero effluent facility in the pharmaceutical industry." (2007): http://hdl.handle.net/10204/1849 |
en_ZA |
dc.identifier.vancouvercitation |
Gouws J, Majozi T, Towards the design of a zero effluent facility in the pharmaceutical industry; 2007. http://hdl.handle.net/10204/1849 . |
en_ZA |
dc.identifier.ris |
TY - Conference Presentation
AU - Gouws, JF
AU - Majozi, T
AB - One of the main goals of any production facility is to have the least negative effect on the surrounding environment, while still producing the required output. The perfect scenario would be a production facility that produces zero effluents. The pharmaceutical production industry has some unique characteristics that make it possible to reach the goal of zero effluent. In such industries wastewater is generally produced from washing out of mixing vessels. The wastewater thus contains valuable product residue. It is possible, under the correct conditions, to reuse the wastewater as part of the formulation of a subsequent batch of a compatible product, thereby producing zero effluent from the operation. From this the question arises on the design of the production facility as to maximise the opportunity to reuse the wastewater, thus producing zero effluent, and keeping the capital costs of such a plant to a minimum. The derived methodology addresses the design aspect of a zero effluent pharmaceutical facility. The methodology takes storage and scheduling of the pharmaceutical operation into consideration.
DA - 2007-05
DB - ResearchSpace
DP - CSIR
KW - Zero effluent
KW - Batch processing
KW - pharmaceutical production
LK - https://researchspace.csir.co.za
PY - 2007
T1 - Towards the design of a zero effluent facility in the pharmaceutical industry
TI - Towards the design of a zero effluent facility in the pharmaceutical industry
UR - http://hdl.handle.net/10204/1849
ER -
|
en_ZA |